Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PROLIXIN DECANOATE

FLUPHENAZINE DECANOATE

Standard Dose
25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PROLIXIN DECANOATE is listed in Drugs@FDA under application 016727 (NDA).

Marketing status: Discontinued Active ingredient FLUPHENAZINE DECANOATE Form and strength INJECTABLE;INJECTION - 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2009-03-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview PROLIXIN DECANOATE is listed in Drugs@FDA under application 016727 (NDA). Marketing status: Discontinued Active ingredient FLUPHENAZINE DECANOATE Form and strength INJECTABLE;INJECTION - 25MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 2009-03-13 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.